News

SME Call: Entrepreneurs leading the way….

Building on the momentum of a triumphant start in 2023, the success of our pilot SME call has paved the way for its continuation into 2024. For this reason, a perfect timing to dive deeper into the call. For this purpose, we spoke to Jochem Christiaansen from Health~Holland and Robbert Wever from hollandbio, both involved in the setup of the call from the beginning. In addition, we invited Aisling Foley and Ilaria Poledri, founders of ExCulture B.V. for an interview to talk more about their experience as applicants within the pilot call.
Image

LifeSciences@Work high in the Financial Times list of Europe's Leading Startup Hubs

Great news! The Financial Times took on the project to map out Europe’s incubators and accelerators boosting tech entrepreneurship.
Passion

Venture Challenge evaluated to be highly effective and efficient

The LifeSciences@Work Venture Challenge
Banner

ALS Medication Development Hits Roadblock but Holds Promise: Insights from Treeway CEO

An interview with Inez de Greef, CEO Treeway Translated from Dutch, original article from the VIG
inez

Scope BioSciences Secures €2.5 Million EIC-Transition Grant

Wageningen, The Netherlands – Venture Challenge alumnus Scope Biosciences announces the award of a €2.5 million EIC Transition grant, a testament to its groundbreaking work in molecular diagnostics.
Scope

Operating with VR: 'Erasmus MC Can't Do Without'

Translated from Dutch Original author: Thijs Baas
Medical VR

Sirius Medical Celebrates the Enrollment of the First Patient in the MELODY Study with Pintuition®

Eindhoven, Netherlands – Sirius Medical is proud to celebrate the enrollment of the first patient in the MELODY Study using the innovative Sirius Pintuition System by Prof. Dr. Banys-Paluchowski.
foto

Apply now for the Venture Challenge Spring 2024

On 1 January 2024 a new application round of the Venture Challenge has opened.
Winner VC23 fall

RIBOPRO Secures €1.9 Million in Convertible Loan, Accelerating Progress in mRNA Technology and Series A Funding

Oss, Netherlands, January 10, 2024 — RIBOPRO, a leading biotechnology company specializing in supporting biotech and bio-pharma through the co-creation of innovative mRNA drugs based on patented mRNA technologies and high-quality mRNA/LNP producti
banner

NutriLeads Completes 4.5 Million Euro Series C Financing to Accelerate Commercialization of BeniCaros as a Global Precision Prebiotic Brand

Company also announces Board and Management changes and new scientific advisory board December 18, 2023 – NutriLeads BV today announced that it has raised 4.5 million euros in a Series C investment round to accelerate the commercializatio
Nutrileads